Inventor · disambiguated record
Xiaoyan Jiang
Also filed as: JIANG XIAOYAN · JIANG XIAOYAN JANE
11 granted patents·20 pending applications·9 citations·filing 2009–2025
82Inventor score
Files withALIBABA GROUP HOLDING LTD7BIOHENG THERAPEUTICS LTD6NANJING BIOHENG BIOTECH CO LTD5TSUBOTA LAB INC5JIANG XIAOYAN2
Top patents by PatentIndex Score
31 records- 0176US11276013B2Method and apparatus for training model based on random forestALIBABA GROUP HOLDING LTD·Filed 2018·Granted Mar 15, 2022·2 cites·14 claims
- 0275US12478597B2Mouse myopia-induced model and endoplasmic reticulum stress suppressant for preventing and suppressing myopiaTSUBOTA LAB INC·Filed 2019·Granted Nov 25, 2025·1 cites·6 claims
- 0375US2024210736A1Mouse myopia-induced model and endoplasmic reticulum stress suppressant for preventing and suppressing myopiaTSUBOTA LAB INC·Filed 2024·Application pending·0 cites
- 0468US12466093B2Electric hair clipperJIANG XIAOYAN·Filed 2025·Granted Nov 11, 2025·0 cites·14 claims
- 0565USD968843SSoap dispenserLIAO PAN·Filed 2022·Granted Nov 8, 2022·3 cites·1 claims
- 0665US2025064855A1Use of dual-target CAR-T cells in treating B-cell autoimmune diseasesGRACELL BIOTECHNOLOGIES SHANGHAI CO LTD·Filed 2024·Application pending·0 cites
- 0763USD1080069SHair curlerJIANG XIAOYAN·Filed 2024·Granted Jun 17, 2025·2 cites·1 claims
- 0858US11551036B2Methods and apparatuses for building data identification modelsALIBABA GROUP HOLDING LTD·Filed 2018·Granted Jan 10, 2023·0 cites·17 claims
- 0957US10956395B2Association analysis method and apparatusALIBABA GROUP HOLDING LTD·Filed 2018·Granted Mar 23, 2021·0 cites·17 claims
- 1056US2024398736A1Eyedrops for Treating Scleral Thinning and Screening Method for Therapeutic Agent of Scleral ThinningTSUBOTA LAB INC·Filed 2021·Application pending·0 cites
- 1156US2024041806A1Eyedrops for Inhibiting Myopia Progression in Children and Screening Method for Inhibitor of Myopia Progression in ChildrenTSUBOTA LAB INC·Filed 2021·Application pending·0 cites
- 1252US2023399398A1Cd7-targeting humanized antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1352US2023390336A1Chimeric antigen receptor targeting cd7 and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1451USD981136SSoap dispenserLIAO PAN·Filed 2022·Granted Mar 21, 2023·1 cites·1 claims
- 1551US2024018236A1Cd19-targeting humanized antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1651US2024052029A1Ror1-targeting antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1750US11188731B2Feature data processing method and deviceALIBABA GROUP HOLDING LTD·Filed 2018·Granted Nov 30, 2021·0 cites·18 claims
- 1850US2024082306A1Novel chimeric antigen receptor and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1950US2024043532A1Nkg2a-targeting antibody and use thereofBIOHENG THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2049US2023364441A1Device and method for inhibiting choroidal thinningTSUBOTA LAB INC·Filed 2021·Application pending·0 cites
- 2148US11615346B2Method and system for training model by using training dataALIBABA GROUP HOLDING LTD·Filed 2018·Granted Mar 28, 2023·0 cites·18 claims
- 2248US2024009308A1Chimeric antigen receptor comprising novel co-stimulatory domain and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2348US2023270858A1Novel co-stimulatory domain and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2447US2023242661A1Engineered immune cell expressing nk inhibitory molecule and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2546US2023248768A1Engineered immune cell for allotransplantationNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2646US2011002435A1Nuclear fuel assembly support gridWESTINGHOUSE ELECTRIC CORP·Filed 2009·Application pending·0 cites
- 2745US12097194B2Combination therapy for treating blood cancerSIGNALCHEM LIFESCIENCES CORP·Filed 2019·Granted Sep 24, 2024·0 cites·12 claims
- 2842US2024277843A1Novel chimeric antigen receptor and use thereofNANJING BIOHENG BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2941US2018330226A1Question recommendation method and deviceALIBABA GROUP HOLDING LTD·Filed 2018·Application pending·0 cites
- 3037US2019034516A1Method and apparatus for acquiring an evaluation indexALIBABA GROUP HOLDING LTD·Filed 2017·Application pending·0 cites
- 3136US2016002626A1Tox inhibition for the treatment of cancerZHOU YOUWEN·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaoyan Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →